Save the date for MRF & ISSAD Conference 2021

09 Jul 2021
Save the date for MRF & ISSAD Conference 2021

Meningitis Research Foundation Conference
1st - 3rd November 2021

Registration is not yet open. Further information will be available soon.

The thirteenth Meningitis Research Foundation Conference will bring together world-leading experts discussing latest advances and today's challenges for meningitis and septicaemia, including burden and impact of diseases, the development of new vaccines and global impact of existing programmes and campaigns, the development of new diagnostic tests, advances and controversies in treatment, scientific advances to enable future action against these infections, aftercare and advocacy. The conference programme is aligned to the new WHO Global Roadmap to Defeat Meningitis by 2030.

We are now inviting submission of poster abstracts to be considered for display at our Meningitis Research Foundation Conference 2021.

The Steering Committee will consider abstracts on any form of meningitis, sepsis, or associated infections, from a scientific or healthcare perspective, including prevention, diagnosis, recognition and treatment, health systems research, sequelae and their management, pathogenesis, pathophysiology, epidemiology, health economics, disease burden, immunology, or microbiology. Abstracts need to be submitted to one of the following categories:

  1. 1. Prevention and epidemic control

  2. 2. Diagnosis and treatment

  3. 3. Disease surveillance

  4. 4. Support and care for people affected by meningitis

  5. 5. Advocacy and engagement

If you are unsure which category your poster best fits under, please contact Liz Rodgers ( to discuss this further.

Please submit your poster abstract on this form and e-mail it to Liz ( by Monday 6th September 2021.

The abstracts should be written in English and the presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.

Abstracts accepted will be published on the virtual conference platform and after the conference will also be made available on our website.

Instructions for preparation of posters will be sent together with the acceptance notification. Authors of the top fifteen abstracts will be invited to give a short (5 minute) oral presentation of their work at the conference. All authors of accepted abstracts will be asked to send in a pdf/powerpoint copy of their poster before the conference for consideration by the Steering Committee, who will award a prize for the best poster (NB: the best poster prize will not necessarily be awarded to one of the poster presenters).

Presenting authors must be registered delegates. Booking will soon open on this conference webpage. There is a discount for junior trainees (below the grade of specialty registrar) nurses, post-docs and those residing for more than 60% of the year in countries classified with low income and lower-middle income economies.


The steering committee for Meningitis Research Foundation Conference 2021:

  • Dr Ifedayo Adetifa, KEMRI-Wellcome Trust/LSHTM
  • Dr Mark Alderson, PATH
  • Professor Ray Borrow, Public Health England, Vaccine Evaluation Unit, Manchester
  • Professor Dominique Caugant, NIPH
  • Professor Sir Brian Greenwood, LSHTM
  • Professor Paul Heath, SGUL
  • Professor Robert Heyderman, UCL
  • Prof Beate Kampmann, LSHTM
  • Dr Brenda Kwambana Adams, UCL
  • Dr Senjuti Saha, Child Health Research Foundation, Dhaka, Bangladesh
  • Dr Matthew Snape, Oxford Vaccine Group
  • Professor James Stuart, University of Bristol/ WHO
  • Dr Caroline Trotter, University of Cambridge
  • Dr Anne von Gottberg, National Institute for Communicable Diseases (NICD), Johannesburg
  • Linda Glennie, Meningitis Research Foundation
Group B Streptococcus: Accelerating Evidence-based Action for Every Family Everywhere
LAUNCH: WHO’s Value Case Proposition
Wednesday 3rd November from 2 pm (FREE ONLINE)
Hosted by The London School of Hygiene & Tropical Medicine with WHO and Meningitis Research Foundation, plus many partners

Worldwide over 20 million pregnant women are estimated to be affected by Group B Streptococcal infection. To date most focus has been on infections in children, yet there are many additional consequences for women themselves, including stillbirths, preterm birth and long-term impacts for affected survivors.

The WHO-led Value Case Proposition includes years of work by many teams from all over the world on new data, analysis regarding long-term health and economic consequences of GBS disease, and estimated costs/benefits of vaccination or other prevention approaches.

The report findings will be relevant for families, policymakers, clinicians, scientists, & industry. There will be a particular spotlight on meningitis and this Report is linked to the WHO Global Roadmap to Defeat Meningitis by 2030. 
International Symposium on Streptococcus agalactiae Disease (ISSAD2021)
Thursday 4th to Friday 5th November

The second International Symposium on Streptococcus agalactiae Disease (ISSAD2021) will convene stakeholders sharing the latest science to accelerate progress against GBS, including meningitis. As well as dynamic and diverse plenaries, there will be interactive parallel sessions, a poster competition with scholarships, and mentoring for next generation low- and middle-income country scientists.

Conference content will span discovery (genomics and host response), through development (including the latest updates on vaccines), to delivery of care in MNCH systems. Join us to advance evidence for action against GBS, to protect every family everywhere.
Give researchers the clues to help defeat meningitis
Give researchers the clues to help defeat meningitis
£160/€190/$214 decodes the genetic information in a sample of meningococcal bacteria. This information helps us to track new forms of meningitis and campaign to introduce new vaccines.
Liz Rodgers
Research Projects Manager

Hi, I’m Liz and I’m MRF's Research Projects Manager.

If you’d like to know more about this area of MRF's work, do get in touch.

Tel: 0333 405 6258
Share this